ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,701Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 22

$733K Total Retail Price of All Prescriptions

Rank: 5 out of 22

510 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 510 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

16% of this provider’s 510 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 13,977 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 42%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $91 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
AMLODIPINE BESYLATE 657 592 1 13
WARFARIN SODIUM 622 622 2 26
OMEPRAZOLE 558 520 3 17
SIMVASTATIN 556 498 4 4
METOPROLOL TARTRATE 529 510 5 18
LISINOPRIL 519 481 6 10
HYDROCODONE-ACETAMINOPHEN 463 328 S3 7 22
LEVOTHYROXINE SODIUM 460 417 8 1
ATORVASTATIN CALCIUM 396 360 9 11
FUROSEMIDE 384 371 10 25
TRAZODONE HCL 355 349 11 48
PRAVASTATIN SODIUM 328 276 12 19
SERTRALINE HCL 284 273 13 41
HYDROCHLOROTHIAZIDE 189 162 14 23
METOPROLOL SUCCINATE 178 166 15 50
DIOVAN 163 152 16 54
MIRTAZAPINE 162 162 17 65
ZOLPIDEM TARTRATE 159 118 18 49
GABAPENTIN 157 153 19 35
TRIAMTERENE-HCTZ 153 150 20 67
NAMENDA 152 141 21 68
ATENOLOL 151 139 22 33
AZITHROMYCIN 150 110 23 58
METFORMIN HCL 144 142 24 3
TAMSULOSIN HCL 134 127 25 59
LOSARTAN POTASSIUM 132 118 26 20
LIPITOR 129 125 27 53
QUETIAPINE FUMARATE 127 111 28 75
CRESTOR 127 97 28 27
OXYCODONE HCL 125 69 S2 30 76
RANITIDINE HCL 122 122 31 63
ALLOPURINOL 121 121 32 61
ALPRAZOLAM 120 110 33 77
ALENDRONATE SODIUM 116 116 34 32
DONEPEZIL HCL 111 111 35 85
METFORMIN HCL ER 108 97 36 7
GLIPIZIDE 108 95 36 21
PANTOPRAZOLE SODIUM 104 100 38 66
FENOFIBRATE 100 75 39 38
CITALOPRAM HBR 99 89 40 51
ENALAPRIL MALEATE 94 88 41 56
GLIPIZIDE ER 88 70 42 24
TRAMADOL HCL 83 58 43 70
ESCITALOPRAM OXALATE 82 70 44 97
SYNTHROID 80 72 45 2
ADVAIR DISKUS 74 61 46 98
BENAZEPRIL HCL 71 63 47 69
COLCRYS 69 69 48 101
FAMOTIDINE 68 68 49 103
IPRATROPIUM-ALBUTEROL 68 68 49 103
PROAIR HFA 66 35 51 73
TAMIFLU 63 61 52 106
GLIMEPIRIDE 63 58 52 5
FINASTERIDE 61 61 54 108
FELODIPINE ER 61 61 54 108
PREDNISONE 61 56 54 108
LEVOFLOXACIN 59 55 57 111
PAROXETINE HCL 58 58 58 72
GEMFIBROZIL 57 55 59 112
LIDODERM 57 57 59 112
LANTUS SOLOSTAR 56 33 61 15
LANTUS 55 42 62 8
BYSTOLIC 55 38 62 117
HYDRALAZINE HCL 54 54 64 86
LEVOXYL 52 52 65 12
AMLODIPINE BESYLATE-BENAZEPRIL 51 51 66 79
LOSARTAN-HYDROCHLOROTHIAZIDE 51 41 66 88
ISOSORBIDE MONONITRATE ER 51 51 66 87
FLUTICASONE PROPIONATE 50 44 69 84
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.